MedTrace Logo

The Effect of Exercise Dosage on Physical Function, Cognition and Disability Following Critical Illness

NCT03413189 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-09-15

No results posted yet for this study

Summary

Survival following a critical illness continues to improve with ongoing developments in medical management, however evidence shows that this patient group is at a high risk of suffering long term disability. The objectives are to determine if there is a link between the amount of exercise performed in intensive care on the presence of delirium, long term cognition and disability whilst ensuring that patient reported outcomes correlate with actual measured results, and to obtain information on recovery from patients and/or relatives to determine themes.

Conditions

  • Critical Illness

Interventions

OTHER

Review of medical records

Medical records of patients will be reviewed to establish the median and highest level of functional achieved in Intensive Care (intensity) and the percentage of exercise sessions performed (frequency)

OTHER

Assessment of physical and cognitive function

This will be performed in person through the Function Independence Measure (FIM), grip strength, functional reach, 6-minute walk test (6MWT) and Montreal Cognitive Assessment (MoCA-Blind).

OTHER

Interview of patients, carers and/or family members

Questions will be asked to participants regarding their recovery from Intensive Care to establish themes

Sponsors & Collaborators

  • Monash Health

    collaborator OTHER

  • Monash University

    collaborator OTHER

  • Australian and New Zealand Intensive Care Research Centre

    lead OTHER

Principal Investigators

  • Carol Hodgson, A/Prof · Australian and New Zealand intensive Care Reserch Centre

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2020-12-30
Completion
2023-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03413189 on ClinicalTrials.gov